Tumor suppressor activity of glucocorticoid receptor in the prostate (original) (raw)

• Ananthanarayanan V, Deaton RJ, Yang XJ, Pins MR, Gann PH . (2005). Alpha-methylacyl-CoA Racemase (AMACR) expression in normal prostatic glands and high-grade prostatic intraepithelial neoplasia (HGPIN): association with diagnosis of prostate cancer. Prostate 63: 341–346.
  Article CAS Google Scholar
• Bourcier T, Forgez P, Borderie V, Scheer S, Rostene W, Laroche L . (2000). Regulation of human corneal epithelial cell proliferation and apoptosis by dexamethasone. Invest Ophthalmol Vis Sci 41: 4133–4141.
  CAS PubMed Google Scholar
• Bruna A, Nicolas M, Munoz A, Kyriakis JM, Caelles C . (2003). Glucocorticoid receptor–JNK interaction mediates inhibition of the JNK pathway by glucocorticoids. EMBO J 22: 6035–6044.
  Article CAS Google Scholar
• Budunova IV, Carbajal S, Kang H, Viaje A, Slaga TJ . (1997). Altered glucocorticoid receptor expression and function during mouse skin carcinogenesis. Mol Carcinogen 18: 177–185.
  Article CAS Google Scholar
• Chen Z, Fan Z, McNeal JE, Nolley R, Caldwell MC, Mahadevappa M et al. (2003). Hepsin and maspin are inversely expressed in laser capture microdissectioned prostate cancer. J Urol 169: 1316–1319.
  Article CAS Google Scholar
• De Bosscher K, Vanden Berghe W, Haegeman G . (2003). The interplay between the glucocorticoid receptor and nuclear factor-kappaB or activator protein-1: molecular mechanisms for gene repression. Endocr Rev 24: 488–522.
  Article CAS Google Scholar
• Dhanasekaran SM, Barrette TR, Ghosh D, Shah R, Varambally S, Kurachi K et al. (2001). Delineation of prognostic biomarkers in prostate cancer. Nature 412: 822–826.
  Article CAS Google Scholar
• Fakih M, Johnson CS, Trump DL . (2002). Glucocorticoids and treatment of prostate cancer: a preclinical and clinical review. Urology 60: 553–561.
  Article Google Scholar
• Fixemer T, Remberger K, Bonkhoff H . (2003). Differential expression of the estrogen receptor beta (ERbeta) in human prostate tissue, premalignant changes, and in primary, metastatic, and recurrent prostatic adenocarcinoma. Prostate 54: 79–87.
  Article CAS Google Scholar
• Gioeli D, Black BE, Gordon V, Spencer A, Kesler CT, Eblen ST et al. (2006). Stress kinase signaling regulates androgen receptor phosphorylation, transcription, and localization. Mol Endocrinol 20: 503–515.
  Article CAS Google Scholar
• Greenberg AK, Hu J, Basu S, Hay J, Reibman J, Yie TA et al. (2002). Glucocorticoids inhibit lung cancer cell growth through both the extracellular signal-related kinase pathway and cell cycle regulators. Am J Respir Cell Mol Biol 27: 320–328.
  Article CAS Google Scholar
• Greenstein S, Ghias K, Krett NL, Rosen ST . (2002). Mechanisms of glucocorticoid-mediated apoptosis in hematological malignancies. Clin Cancer Res 8: 1681–1694.
  CAS Google Scholar
• Grossmann ME, Huang H, Tindall DJ . (2001). Androgen receptor signaling in androgen-refractory prostate cancer. J Natl Cancer Inst 93: 1687–1697.
  Article CAS Google Scholar
• Jiang X, Norman M, Roth L, Li X . (2004). Protein-DNA array-based identification of transcription factor activities regulated by interaction with the glucocorticoid receptor. J Biol Chem 279: 38480–38485.
  Article CAS Google Scholar
• Jiang Z, Woda BA . (2004). Diagnostic utility of alpha-methylacyl CoA racemase (P504S) on prostate needle biopsy. Adv Anat Pathol 11: 316–321.
  Article CAS Google Scholar
• Kassel O, Sancono A, Kratzschmar J, Kreft B, Stassen M, Cato AC . (2001). Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP-1. EMBO J 20: 7108–7116.
  Article CAS Google Scholar
• Klezovitch O, Chevillet J, Mirosevich J, Roberts RL, Matusik RJ, Vasioukhin V . (2004). Hepsin promotes prostate cancer progression and metastasis. Cancer Cell 6: 185–195.
  Article CAS Google Scholar
• Koutsilieris M, Mitsiades C, Dimopoulos T, Vacalicos J, Lambou T, Tsintavis A et al. (2002). Combination of dexamethasone and a somatostatin analogue in the treatment of advanced prostate cancer. Expert Opin Invest Drugs 11: 283–293.
  Article CAS Google Scholar
• Li CL, Johnson GR . (1998). Clonal cultures in vitro for hematopoietic cells using semisolid agar medium. In: Celis JS (ed). Cell Biology: A Laboratory Handbook 2nd edn, vol. 1. Academic Press: San-Diego (CA), pp 172–177.
  Google Scholar
• Maroni PD, Koul S, Meacham RB, Koul HK . (2004). Mitogen activated protein kinase signal transduction pathways in the prostate. Cell Commun Signal 2: 5–12.
  Article Google Scholar
• Mimeault M, Pommery N, Henichart JP . (2003). New advances on prostate carcinogenesis and therapies: involvement of EGF–EGFR transduction system. Growth Factors 21: 1–14.
  Article CAS Google Scholar
• Mohler JL, Chen Y, Hamil K, Hall SH, Cidlowski JA, Wilson EM et al. (1996). Androgen and glucocorticoid receptors in the stroma and epithelium of prostatic hyperplasia and carcinoma. Clin Cancer Res 2: 889–895.
  CAS PubMed Google Scholar
• Necela BM, Cidlowski JA . (2004). Mechanisms of glucocorticoid receptor action in noninflammatory and inflammatory cells. Proc Am Thorac Soc 1: 239–246.
  Article CAS Google Scholar
• Nishimura K, Nonomura N, Satoh E, Harada Y, Nakayama M, Tokizane T et al. (2001). Potential mechanism for the effects of dexamethasone on growth of androgen-independent prostate cancer. J Natl Cancer Inst 93: 1739–1746.
  Article CAS Google Scholar
• Peterziel H, Mink S, Schonert A, Becker M, Klocker H, Cato AC . (1999). Rapid signalling by androgen receptor in prostate cancer cells. Oncogene 18: 6322–6329.
  Article CAS Google Scholar
• Quinn DI, Henshall SM, Sutherland RL . (2005). Molecular markers of prostate cancer outcome. Eur J Cancer 41: 858–887.
  Article CAS Google Scholar
• Ray DW . (1996). Molecular mechanisms of glucocorticoid resistance. J Endocrinol 149: 1–5.
  Article CAS Google Scholar
• Ricote M, Garcia-Tunon I, Bethencourt F, Fraile B, Onsurbe P, Paniagua R et al. (2006). The p38 transduction pathway in prostatic neoplasia. J Pathol 208: 401–407.
  Article CAS Google Scholar
• Rosenberg I . (1996). Protein Analysis and Purification: Benchtop Techniques. Birkhauser: Boston, MA, pp 103–109.
  Google Scholar
• Schacke H, Docke WD, Asadullah K . (2002). Mechanisms involved in the side effects of glucocorticoids. Pharmacol Ther 96: 23–43.
  Article CAS Google Scholar
• Schaefer JS, Zhang M . (2003). Role of maspin in tumor metastasis and angiogenesis. Curr Mol Med 3: 653–658.
  Article CAS Google Scholar
• Schug J, Overton CG . (2005). TESS: Transcription Element Search Software on the WWW. Eur J Cancer 41: 858–887 (http://www.cbil.upenn.edu/cgi-bin/tess/tess).
  Article Google Scholar
• Torlakovic E, Lilleby W, Berner A, Torlakovic G, Chibbar R, Furre T et al. (2005). Differential expression of steroid receptors in prostate tissues before and after radiation therapy for prostatic adenocarcinoma. Int J Cancer 117: 381–386.
  Article CAS Google Scholar
• Weaver I, Champagne F, Brown S, Dymov S, Sharma S, Meaney M et al. (2005). Reversal of maternal programming of stress responses in adult offspring through methyl supplementation: altering epigenetic marking later in life. J Neurosci 25: 11045–11054.
  Article CAS Google Scholar
• Wu W, Chaudhuri S, Brickley DR, Pang D, Karrison T, Conzen SD . (2004). Microarray analysis reveals glucocorticoid-regulated survival genes that are associated with inhibition of apoptosis in breast epithelial cells. Cancer Res 64: 1757–1764.
  Article CAS Google Scholar
• Zha S, Ferdinandusse S, Denis S, Wanders RJ, Ewing CM, Luo J et al. (2003). Alpha-methylacyl-CoA racemase as an androgen-independent growth modifier in prostate cancer. Cancer Res 63: 7365–7376.
  CAS PubMed Google Scholar